Abstract | PURPOSE: MATERIALS AND METHODS: Between April 1997 and February 2006, 236 patients with locally advanced, histologically proven, and new or recurrent cancer of the head and neck were treated with carbon ions. The treatment dose was 64.0 GyE/16 fractions/4 weeks (or 57.6 GyE/16 fractions/4 weeks when the wide-range skin was included in the target volume). RESULTS: CONCLUSIONS:
|
Authors | Jun-Etsu Mizoe, Azusa Hasegawa, Keiichi Jingu, Ryo Takagi, Hiroki Bessyo, Takamichi Morikawa, Morio Tonoki, Hiroshi Tsuji, Tadashi Kamada, Hirohiko Tsujii, Yoshitaka Okamoto, Organizing Committee for the Working Group for Head Neck Cancer |
Journal | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
(Radiother Oncol)
Vol. 103
Issue 1
Pg. 32-7
(Apr 2012)
ISSN: 1879-0887 [Electronic] Ireland |
PMID | 22321201
(Publication Type: Clinical Trial, Phase II, Journal Article)
|
Copyright | Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Carbon
(therapeutic use)
- Female
- Head and Neck Neoplasms
(mortality, pathology, radiotherapy)
- Heavy Ion Radiotherapy
- Heavy Ions
(adverse effects)
- Humans
- Male
- Middle Aged
|